Company: Bausch Health
Posted by BnL_EyeCareVet · March 24, 2026
Tags: quota, compensation
Just got back from NSM and I need to process this with people who were there.
They spent two days pumping us up about the Miebo launch momentum and Xdemvy opportunity, had a big celebration for the top performers, and then on day three unveiled our 2026 quotas.
Mine went up 31%.
Thirty-one percent.
On a territory that was at 97% in 2025, which in the current environment is solid.
No rationale document, no methodology explanation.
Just a number.
When I pushed my DM on how it was calculated, the answer was effectively "national number came down, it got allocated." The party and the celebration feel cynical now in retrospect.
You get two days of "you're all stars" followed by quotas that make star performance statistically unlikely.
I've been in pharma 9 years and NSM has never felt so transparently manipulative.
67 upvotes · 5 comments